This aligns with existing literature that identifies chromosomes 17 and 11 as regions frequently involved in breast cancer progression, primarily due to the presence of oncogenes like ERBB2 (Her2) and CCND1, which are known drivers of cell proliferation and tumor growth through gene amplification [36,37]. This evidence concerns the gene ERBB2 and neoplasm.